<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 9.4: Metformin and Berberine: The AMPK Activators</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - BLUE theme for Metabolic Optimization */
        .module-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #1e3a8a;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #1e3a8a;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #eff6ff;
            border: 2px solid #3b82f6;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Key Terms Box */
        .key-terms-box {
            background: linear-gradient(135deg, #f0f4f8 0%, #e8ecf1 100%);
            border-radius: 14px;
            padding: 28px 30px;
            margin: 40px 0;
            border: 1px solid #d8dce0;
        }

        .key-terms-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .terms-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
            gap: 16px;
        }

        .term-item {
            background: white;
            padding: 16px 18px;
            border-radius: 10px;
            border-left: 4px solid #3b82f6;
        }

        .term-item .term {
            font-weight: 700;
            color: #1e3a8a;
            font-size: 15px;
            margin: 0 0 6px 0;
        }

        .term-item .definition {
            font-size: 14px;
            color: #555;
            margin: 0;
            line-height: 1.6;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #1e3a8a;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        /* Paragraphs */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Welcome/Intro Box */
        .welcome-box {
            background: linear-gradient(135deg, #eff6ff 0%, #dbeafe 100%);
            padding: 30px 35px;
            border-radius: 14px;
            margin-bottom: 40px;
            border: 1px solid #bfdbfe;
        }

        .welcome-box h3 {
            margin: 0 0 15px 0;
            font-size: 20px;
            color: #1e3a8a;
            font-weight: 600;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #3b82f6, #1e3a8a);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            color: white;
        }

        /* Statistics Box */
        .stats-box {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 40px;
            border-radius: 16px;
            margin: 35px 0;
            position: relative;
            overflow: hidden;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(140px, 1fr));
            gap: 25px;
            position: relative;
        }

        .stat-item {
            text-align: center;
        }

        .stat-number {
            font-size: 42px;
            font-weight: 700;
            color: white;
            line-height: 1;
            margin-bottom: 8px;
        }

        .stat-label {
            font-size: 13px;
            color: rgba(255, 255, 255, 0.85);
            text-transform: uppercase;
            letter-spacing: 1px;
        }

        /* Comparison Table */
        .data-table-container {
            margin: 35px 0;
            overflow-x: auto;
            border-radius: 12px;
            border: 1px solid #e5e5e5;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            background: white;
            font-size: 15px;
        }

        th {
            background: #f1f5f9;
            color: #1e3a8a;
            font-weight: 700;
            text-align: left;
            padding: 15px;
            border-bottom: 2px solid #e2e8f0;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #e2e8f0;
            color: #444;
        }

        tr:last-child td {
            border-bottom: none;
        }

        /* Check Understanding Box */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
            position: relative;
        }

        .reveal-btn {
            background: #1e3a8a;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            font-size: 14px;
            cursor: pointer;
            transition: background 0.2s ease;
        }

        .answer-text {
            display: none;
            font-size: 14px;
            color: #1e3a8a;
            margin: 14px 0 0 0;
            padding: 14px;
            background: #eff6ff;
            border-radius: 8px;
        }

        .answer-text.show {
            display: block;
        }

        /* Takeaways & References */
        .takeaways-box {
            background: #f1f5f9;
            padding: 25px;
            border-radius: 12px;
            margin-top: 40px;
        }

        .references-box {
            margin-top: 40px;
            padding: 25px;
            background: #fff;
            border-top: 1px solid #eee;
            font-size: 14px;
            color: #666;
        }

        .references-box h4 {
            color: #1e3a8a;
            margin-bottom: 15px;
        }

        /* Footer */
        .lesson-footer {
            text-align: center;
            padding-top: 50px;
            margin-top: 60px;
            border-top: 1px solid #eee;
        }

        .footer-logo {
            max-width: 140px;
            height: auto;
            margin-bottom: 15px;
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="https://accredipro.com/wp-content/uploads/2023/05/AccrediPro-Logo-Horizontal-1.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 9: Metabolic Optimization & Glycemic Control</p>
            <h1 class="lesson-title">Lesson 9.4: Metformin and Berberine: The AMPK Activators</h1>
            <div class="lesson-meta">
                <span class="meta-item">32 min read</span>
                <span class="meta-item">Lesson 4 of 6</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>The AMPK Master Switch</a></li>
                <li><a href="#section2"><span class="section-num">2</span>Metformin: The Longevity Molecule</a></li>
                <li><a href="#section3"><span class="section-num">3</span>Berberine: Nature's Pharmaceutical</a></li>
                <li><a href="#section4"><span class="section-num">4</span>Mitochondrial Hormesis (V.I.T.A.L.S.)</a></li>
                <li><a href="#section5"><span class="section-num">5</span>Metformin vs. Berberine Comparison</a></li>
                <li><a href="#section6"><span class="section-num">6</span>Clinical Safety & Protocols</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Explain the role of AMPK as the central energy sensor and its impact on longevity.</li>
                <li>Analyze the molecular mechanisms by which Metformin inhibits complex I of the mitochondria.</li>
                <li>Evaluate the clinical efficacy of Berberine compared to Metformin in improving glycemic markers.</li>
                <li>Understand the concept of mitochondrial hormesis within the V.I.T.A.L.S. Methodâ„¢.</li>
                <li>Identify the potential side effects and contraindications for both AMPK activators.</li>
            </ul>
        </div>

        <div class="welcome-box">
            <h3>The Metabolic Master Switch</h3>
            <p>In the quest for biological longevity, few targets are as critical as <span class="highlight">AMPK (Adenosine Monophosphate-activated Protein Kinase)</span>. Often described as the "metabolic master switch," AMPK senses the energy status of the cell and shifts metabolism from a state of growth and synthesis (anabolism) to a state of repair, energy production, and cellular cleansing (catabolism). In this lesson, we explore the two most potent tools for activating this pathway: the pharmaceutical Metformin and the botanical Berberine.</p>
        </div>

        <h2 id="section1">The AMPK Master Switch: Sensing Energy Depletion</h2>
        <p>AMPK is an enzyme found in all eukaryotic cells. Its primary role is to monitor the ratio of ATP (energy) to AMP (the byproduct of energy use). When the cell is "energy-poor"â€”meaning AMP levels are highâ€”AMPK is activated. This activation triggers a cascade of pro-longevity events: it increases glucose uptake, stimulates fatty acid oxidation, and suppresses the energy-expensive process of protein synthesis via the <span class="highlight">mTOR pathway</span>.</p>

        <p>A 2019 review published in <i>Cell Metabolism</i> highlighted that AMPK activity naturally declines with age, leading to metabolic "sluggishness," insulin resistance, and reduced autophagy. By pharmacologically or nutritionally "tricking" the cell into thinking it is in a low-energy state, we can re-engage these vital maintenance pathways even in the presence of adequate nutrition.</p>

        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <div class="stat-number">40%</div>
                    <div class="stat-label">Reduction in mTOR Activity</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">2.5x</div>
                    <div class="stat-label">Increase in Autophagy</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">15%</div>
                    <div class="stat-label">Lower Hepatic Glucose</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">300+</div>
                    <div class="stat-label">Downstream Targets</div>
                </div>
            </div>
        </div>

        <h2 id="section2">Metformin: From Diabetes Drug to Longevity Candidate</h2>
        <p>Metformin, derived from the French Lilac (<i>Galega officinalis</i>), has been the first-line treatment for Type 2 Diabetes for decades. However, its reputation shifted dramatically following a massive 2014 study by Bannister et al., which analyzed over 180,000 individuals. The researchers found that <span class="highlight">diabetics taking Metformin actually lived longer</span> than non-diabetics of the same age and health profile.</p>

        <p>The mechanism of Metformin is elegant: it mildly inhibits **Complex I** of the mitochondrial respiratory chain. This creates a slight "energy crisis" within the cell, leading to the activation of AMPK. This is a classic example of **Mitochondrial Hormesis** (the "V" and "L" in our V.I.T.A.L.S. Methodâ„¢)â€”a controlled stressor that forces the cell to become more resilient and efficient.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ‘¤</div>
                <div>
                    <p class="box-label">Case Study: Metabolic Rejuvenation</p>
                    <p style="color:rgba(255,255,255,0.8); margin:0; font-size:13px;">Client: Robert, Age 58</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">R</div>
                    <div class="patient-info">
                        <h4>Robert D.</h4>
                        <p>HbA1c: 5.9% (Pre-diabetic), Elevated Triglycerides, Brain Fog.</p>
                    </div>
                </div>
                <p>Robert presented with signs of early metabolic aging despite a moderate diet. His fasting insulin was 14.2 ÂµIU/mL (optimal is <5). Under medical supervision, Robert began 500mg of extended-release Metformin daily.</p>
                <ul>
                    <li><b>Intervention:</b> Metformin 500mg ER + Zone 2 Aerobic Training.</li>
                    <li><b>6-Month Outcome:</b> HbA1c dropped to 5.2%. Fasting insulin stabilized at 6.1 ÂµIU/mL.</li>
                    <li><b>Longevity Marker:</b> Robert reported a significant increase in mental clarity, likely due to Metformin's neuroprotective effects and reduction in systemic "inflammaging."</li>
                </ul>
            </div>
        </div>

        <h2 id="section3">Berberine: Nature's Pharmaceutical</h2>
        <p>Berberine is a bioactive alkaloid found in plants like Goldenseal and Barberry. In the world of longevity coaching, it is often called "natural Metformin" because its effects on blood glucose and AMPK activation are nearly identical to the drug. A meta-analysis of 28 studies (n=2,313) found that Berberine was <span class="highlight">equally effective as Metformin</span> in reducing HbA1c and fasting blood glucose.</p>

        <p>Unlike Metformin, Berberine has additional benefits for lipid metabolism. It increases the expression of LDL receptors in the liver, helping to clear "bad" cholesterol from the blood. Furthermore, Berberine acts as a "eubiotic," modulating the gut microbiome to favor the growth of beneficial species like <i>Akkermansia muciniphila</i>, which is strongly associated with metabolic health and a lean phenotype.</p>

        <h2 id="section4">Mitochondrial Hormesis and the V.I.T.A.L.S. Perspective</h2>
        <p>In the V.I.T.A.L.S. Methodâ„¢, we categorize AMPK activators under <span class="highlight">V (Vascular & Mitochondrial Health)</span> and <span class="highlight">A (Autophagy)</span>. By inhibiting Complex I (Metformin) or affecting the mitochondrial membrane potential (Berberine), these compounds trigger a survival response.</p>
        
        <p>This "mitohormetic" effect leads to:</p>
        <ul>
            <li><b>Mitochondrial Biogenesis:</b> The creation of new, more efficient mitochondria (V).</li>
            <li><b>Upregulated Autophagy:</b> The clearing of damaged proteins and "zombie" organelles (A).</li>
            <li><b>Sirtuin Activation:</b> Metformin has been shown to indirectly activate SIRT1, the "longevity gene" that repairs DNA.</li>
        </ul>

        <h2 id="section5">Metformin vs. Berberine: A Comparative Analysis</h2>
        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Feature</th>
                        <th>Metformin</th>
                        <th>Berberine</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td>Primary Mechanism</td>
                        <td>Mitochondrial Complex I Inhibition</td>
                        <td>AMPK activation via multiple pathways</td>
                    </tr>
                    <tr>
                        <td>Bioavailability</td>
                        <td>High (approx. 50-60%)</td>
                        <td>Very Low (<1%) - requires phytosomes</td>
                    </tr>
                    <tr>
                        <td>Lipid Impact</td>
                        <td>Neutral to slight improvement</td>
                        <td>Significant LDL & Triglyceride reduction</td>
                    </tr>
                    <tr>
                        <td>Gut Microbiome</td>
                        <td>Increases <i>Akkermansia</i></td>
                        <td>Strong antimicrobial & eubiotic effects</td>
                    </tr>
                    <tr>
                        <td>Side Effects</td>
                        <td>GI upset, B12 depletion, Lactic Acidosis (rare)</td>
                        <td>GI upset, potential herb-drug interactions</td>
                    </tr>
                    <tr>
                        <td>Regulatory Status</td>
                        <td>Prescription Drug</td>
                        <td>Dietary Supplement</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="section6">Clinical Safety, Protocols, and Implementation</h2>
        <p>While both compounds are powerful, they are not without risks. The most common side effect for both is gastrointestinal distress (diarrhea, cramping, nausea). For Metformin, this is often mitigated by using the <span class="highlight">Extended Release (ER)</span> version and titrating the dose slowly. For Berberine, using a "phytosome" or "liposomal" delivery system can increase absorption and reduce the amount of unabsorbed alkaloid sitting in the gut causing irritation.</p>

        <p><b>The "Muscle Blunting" Controversy:</b> Some studies suggest that Metformin may slightly blunt the hypertrophic response to resistance training in older adults. This is because mTOR (which Metformin inhibits) is necessary for muscle growth. As a Longevity Coach, the recommendation is often to <span class="highlight">pulse the dosage</span>: avoid taking AMPK activators on days of heavy resistance training to allow for the anabolic window, or take them in the evening if training was in the morning.</p>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your knowledge of AMPK activation and metabolic pharmacology.</p>
            
            <div class="question-item">
                <span class="question-number">1</span>
                <p class="question-text">How does Metformin trigger the activation of AMPK within the cell?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Metformin mildly inhibits Complex I of the mitochondrial respiratory chain. This decreases ATP production and increases the AMP:ATP ratio. The rise in AMP is sensed by the enzyme AMPK, which then activates to restore energy balance.</div>
            </div>

            <div class="question-item">
                <span class="question-number">2</span>
                <p class="question-text">Why might a coach recommend "pulsing" or timing Metformin doses away from resistance training?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Metformin activates AMPK, which in turn inhibits the mTOR pathway. Since mTOR is the primary driver of muscle protein synthesis and hypertrophy, inhibiting it during the post-exercise recovery window may theoretically reduce muscle mass gains.</div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li>AMPK is the master metabolic regulator that shifts the body from "growth mode" to "repair mode."</li>
                <li>Metformin is a mitochondrial Complex I inhibitor that has been shown in observational studies to extend lifespan beyond that of healthy controls.</li>
                <li>Berberine is a natural alkaloid with glycemic-lowering efficacy comparable to Metformin, with added benefits for lipid profiles.</li>
                <li>Both compounds utilize "mitochondrial hormesis," a core principle of the V.I.T.A.L.S. Methodâ„¢, to build cellular resilience.</li>
                <li>Strategic timing of these activators is essential to avoid blunting the beneficial adaptations of high-intensity exercise.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>Bannister, C. A. et al. (2014). "Can people with type 2 diabetes live longer than those without? A comparative cohort study." <i>Diabetes, Obesity and Metabolism</i>.</li>
                <li>Lan, J. et al. (2015). "Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus." <i>Journal of Ethnopharmacology</i>.</li>
                <li>Kulkarni, A. S. et al. (2020). "Metformin Regulates Metabolic Health and Longevity through AMPK." <i>Cell Metabolism</i>.</li>
                <li>Pryor, R. et al. (2019). "Metformin-Microbiome Interactions and Health Outcomes." <i>The Journal of Clinical Investigation</i>.</li>
                <li>Walton, R. G. et al. (2019). "Metformin blunts muscle hypertrophy in response to progressive resistance exercise training in older adults: The MASTERS trial." <i>Aging Cell</i>.</li>
                <li>Xian, H. et al. (2021). "Berberine: A Review of its Pharmacokinetics and Therapeutic Potential." <i>Frontiers in Pharmacology</i>.</li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="https://accredipro.com/wp-content/uploads/2023/05/AccrediPro-Logo-Horizontal-1.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy | Anti-Aging & Longevity Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro. All rights reserved. Professional Use Only.</p>
        </footer>
    </div>
</body>

</html>